Mounjaro Subcutaneous Injections 5 mg for diabetes mellitus (terzipatideб Ozempic analogue)

 

Package details: standard kit

 

Manufacturer: Mitsubishi Tanabe Pharma Corporation, Japan

 

Active ingredients: tirzepatide (chemical formula C225H348N48O68)

 

Medical effect: improving action of insulin and blood sugar level

 

Contraindications and precautions: do not use for the following patients:

Patients should follow their prescribed diet and exercise routines diligently. Regularly monitor your blood sugar and urine sugar levels while taking this medication. The medication may lead to hypoglycemia (low blood sugar). Exercise caution during activities with potential risks, such as working at heights or driving. Inform your family and those around you about the potential risk of hypoglycemia. If symptoms like intense hunger, cold sweats, or trembling limbs occur, promptly consume sugar or sugar-rich foods. In case of any unusual symptoms (severe abdominal pain accompanied by vomiting, a palpable lump in your neck, significant weight loss, vision loss or a narrowing field of vision, continuous diarrhea, weakness, dizziness, or lightheadedness, consult with your doctor immediately. For pregnant women or those planning to become pregnant, be aware of the potential fetal toxicity reported in animal studies. Consult with your doctor before using this medication.

If an allergic reaction occurs, stop taking the medicine and consult with your doctor. If you’re taking any other medication, please consult with your doctor before use.

 

 

For adults: start with injecting 2.5 mg subcutaneously once a week. After 4 weeks, increase to the maintenance dose of 5 mg subcutaneously once a week. Your doctor may adjust the dosage according to your condition. If the effect is insufficient even after injection of 5 mg once a week, the dosage can be increased by the steps of 2.5 mg with the intervals of 4 weeks or longer between the steps. However, the maximum dose is 15 mg once a week. 

Please note that this medicine contains 5 mg of the active ingredient in a kit. 

This medicine should be injected on the same day each week.

This medicine is injected into the skin (subcutaneous injection) of your stomach area (abdomen), upper leg (thigh). You may inject Mounjaro subcutaneously in the upper arm if you have the assistance of qualified medical staff. Each time when you are injecting to the same area of your body, a different injection spot should be used.